ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2291

The Factors That Might be Responsible for the Improvement of Fibromyalgia Patients: A Sub-Group That Improved Significantly over Three to Six Months

Robert S. Katz1 and Lauren Kwan2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibromyalgia, medication and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: In a rheumatology office practice, patients with fibromyalgia who improved significantly in their symptoms are seen commonly.  We evaluated patients whose pain, fatigue, fibrofog, and functional scores were significantly better over a 3-6 month period.

Methods: Patients who had significant improvement on visual analog scales in a rheumatology office practice were further assessed and responded to a questionnaire regarding reasons for improvement.

Results:   19 patients indicated significant improvement in their fibromyalgia symptoms and are included. The mean age of the participants was 42.2 (17 years old -71 years old).  17 of the 19 (89.5%) participants were female and 2 of 19 (10.5%) participants were male.  All patients met the 2010 ACR criteria for the diagnosis of fibromyalgia.  The mean pain score at the last office visit was 4.8 on a 1-10 visual analog scale.  The mean pain score at an office visit 3 months earlier was 7.7 and the mean pain score at an office visit 6 months earlier was 8.4.  Patients were asked to list the factors they attributed to their decrease in pain scores of at least 3 points on a 1-10 visual analog scale over the last 6 months.  15 of 19 (78.9%) of patients cited medication as a reason for their improvement.  These medications included cyclobenzaprine (9 of 19, 47.4%), amitriptyline (8 of 19, 42.1%), tizanidine (2 of 19, 10.5%), clonazepam (1 of 19, 5.3%), doxepin (1 of 19, 5.3%), hydrocodone (2 of 19, 10.5%), gabapentin (1 of 19, 5.3%), trazodone (1 of 19, 5.3%), chlorzoxazone (1 of 19, 5.3%), and mirtazepine ( 1 of 19, 5.3%). 

The other common reasons cited for improvement included weather changes (5 of 19, 26.3%), increased rest (5 of 19, 26.3%), decreased stress (3 of 19, 15.8%), and improved sleep (3 of 19, 15.8%).  Exercise, physical therapy, acupuncture, increased time off work, and increased knowledge about their diagnosis were other reasons occasionally cited as a reason for improvement.

Conclusion:   Patients with fibromyalgia who improve significantly generally attribute that improvement to a change in their medication, but other reasons are cited, such as weather and increased rest.  Medication, especially muscle relaxants and tricyclics, appears to be an effective strategy for patients with fibromyalgia who improve significantly.


Disclosure: R. S. Katz, None; L. Kwan, None.

To cite this abstract in AMA style:

Katz RS, Kwan L. The Factors That Might be Responsible for the Improvement of Fibromyalgia Patients: A Sub-Group That Improved Significantly over Three to Six Months [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-factors-that-might-be-responsible-for-the-improvement-of-fibromyalgia-patients-a-sub-group-that-improved-significantly-over-three-to-six-months/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-factors-that-might-be-responsible-for-the-improvement-of-fibromyalgia-patients-a-sub-group-that-improved-significantly-over-three-to-six-months/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology